CXCR4 and renal cell carcinoma: HIF2α and NF-κB pathways also play an important role in RCC metastasis, due to the activation of metastasis-associated enhancer (MAE), which amplifies the expression of chemokine receptor CXCR4, thereby inducing pro-metastatic activity [148].